These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 7545666)

  • 21. Non-glycosylated human B7-1(CD80) retains the capacity to bind its counter-receptors.
    Chen A; Meyerson HJ; Salvekar A; Tykocinski ML
    FEBS Lett; 1998 May; 428(3):127-34. PubMed ID: 9654121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Porcine CTLA4-Ig lacks a MYPPPY motif, binds inefficiently to human B7 and specifically suppresses human CD4+ T cell responses costimulated by pig but not human B7.
    Vaughan AN; Malde P; Rogers NJ; Jackson IM; Lechler RI; Dorling A
    J Immunol; 2000 Sep; 165(6):3175-81. PubMed ID: 10975832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. By Binding CD80 and CD86, the Vaccinia Virus M2 Protein Blocks Their Interactions with both CD28 and CTLA4 and Potentiates CD80 Binding to PD-L1.
    Kleinpeter P; Remy-Ziller C; Winter E; Gantzer M; Nourtier V; Kempf J; Hortelano J; Schmitt D; Schultz H; Geist M; Brua C; Hoffmann C; Schlesinger Y; Villeval D; Thioudellet C; Erbs P; Foloppe J; Silvestre N; Fend L; Quemeneur E; Marchand JB
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30918073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interactions of CD80 and CD86 with CD28 and CTLA4.
    Ellis JH; Burden MN; Vinogradov DV; Linge C; Crowe JS
    J Immunol; 1996 Apr; 156(8):2700-9. PubMed ID: 8609386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects of CTLA-4 substitutions on the binding of human CD80 (B7-1) and CD86 (B7-2).
    Morton PA; Fu XT; Stewart JA; Giacoletto KS; White SL; Leysath CE; Evans RJ; Shieh JJ; Karr RW
    J Immunol; 1996 Feb; 156(3):1047-54. PubMed ID: 8557978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential requirement for CD80 and CD80/CD86-dependent costimulation in the lung immune response to an influenza virus infection.
    Lumsden JM; Roberts JM; Harris NL; Peach RJ; Ronchese F
    J Immunol; 2000 Jan; 164(1):79-85. PubMed ID: 10604996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of human inducible costimulator ligand expression and function.
    Aicher A; Hayden-Ledbetter M; Brady WA; Pezzutto A; Richter G; Magaletti D; Buckwalter S; Ledbetter JA; Clark EA
    J Immunol; 2000 May; 164(9):4689-96. PubMed ID: 10779774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genomic organization of the gene coding for the costimulatory human B-lymphocyte antigen B7-2 (CD86).
    Jellis CL; Wang SS; Rennert P; Borriello F; Sharpe AH; Green NR; Gray GS
    Immunogenetics; 1995; 42(2):85-9. PubMed ID: 7541777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD80 and CD86 C domains play an important role in receptor binding and co-stimulatory properties.
    Vasu C; Wang A; Gorla SR; Kaithamana S; Prabhakar BS; Holterman MJ
    Int Immunol; 2003 Feb; 15(2):167-75. PubMed ID: 12578846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cattle CTLA-4, CD28 and chicken CD28 bind CD86: MYPPPY is not conserved in cattle CD28.
    Parsons KR; Young JR; Collins BA; Howard CJ
    Immunogenetics; 1996; 43(6):388-91. PubMed ID: 8606060
    [No Abstract]   [Full Text] [Related]  

  • 31. In silico engineering a CD80 variant with increased affinity to CTLA-4 and decreased affinity to CD28 for optimized cancer immunotherapy.
    Hajihassan Z; Afsharian NP; Ansari-Pour N
    J Immunol Methods; 2023 Feb; 513():113425. PubMed ID: 36638881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of the costimulatory molecule BB-1, the ligands CTLA-4 and CD28, and their mRNA in inflammatory myopathies.
    Murata K; Dalakas MC
    Am J Pathol; 1999 Aug; 155(2):453-60. PubMed ID: 10433938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD80 (B7-1) and CD86 (B7-2): potential targets for immunotherapy?
    van Gool SW; Barcy S; Devos S; Vandenberghe P; Ceuppens JL; Thielemans K; de Boer M
    Res Immunol; 1995; 146(3):183-96. PubMed ID: 8525052
    [No Abstract]   [Full Text] [Related]  

  • 34. B7-CD28 interaction is a late acting co-stimulatory signal for human T cell responses.
    Zhang YQ; Joost van Neerven RJ; Van Gool SW; Coorevits L; de Boer M; Ceuppens JL
    Int Immunol; 1997 Aug; 9(8):1095-102. PubMed ID: 9263006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural basis of inducible costimulator ligand costimulatory function: determination of the cell surface oligomeric state and functional mapping of the receptor binding site of the protein.
    Chattopadhyay K; Bhatia S; Fiser A; Almo SC; Nathenson SG
    J Immunol; 2006 Sep; 177(6):3920-9. PubMed ID: 16951355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of CD80 and CD86 on T cell cytokine production.
    Petro TM; Chen SS; Panther RB
    Immunol Invest; 1995 Nov; 24(6):965-76. PubMed ID: 8575841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of the costimulatory requirements for generating human virus-specific in vitro T helper and effector responses.
    Blazevic V; Trubey CM; Shearer GM
    J Clin Immunol; 2001 Jul; 21(4):293-302. PubMed ID: 11506200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Costimulation of T-cell activation and virus production by B7 antigen on activated CD4+ T cells from human immunodeficiency virus type 1-infected donors.
    Haffar OK; Smithgall MD; Bradshaw J; Brady B; Damle NK; Linsley PS
    Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11094-8. PubMed ID: 7504294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular cloning of the cDNAs encoding the feline B-lymphocyte activation antigen B7-1 (CD80) and B7-2 (CD86) homologues which interact with human CTLA4-Ig.
    Nishimura Y; Shimojima M; Miyazawa T; Sato E; Nakamura K; Izumiya Y; Ikeda Y; Mikami T; Takahashi E
    Eur J Immunogenet; 2000; 27(5-6):427-30. PubMed ID: 11029611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blocking CD40 - CD154 and CD80/CD86 - CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production.
    Van Gool SW; Vermeiren J; Rafiq K; Lorr K; de Boer M; Ceuppens JL
    Eur J Immunol; 1999 Aug; 29(8):2367-75. PubMed ID: 10458748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.